The global NAD+ Health Products market was valued at US$ 577 million in 2025 and is anticipated to reach US$ 1528 million by 2032, at a CAGR of 15.2% from 2026 to 2032.

NAD+ Health Products Market

NAD+ (Nicotinamide Adenine Dinucleotide) is a coenzyme found in all living cells. It plays a crucial role in various biological processes, including energy metabolism, DNA repair, and gene expression. Some people are interested in NAD+ enhancers, which are substances or compounds that may support or increase the levels of NAD+ in the body.

Strong Market Growth Driven by Aging Population and Longevity Demand

The NAD+ booster capsule market is expected to maintain strong growth as global populations age and consumer awareness of longevity, cellular health, and metabolic wellness increases. Capsules remain the most commercially scalable and accessible format, making them the preferred product type for retail brands. Demand is expanding rapidly in North America, Europe, Japan, and China, driven by rising interest in anti-aging science and the shift toward preventive healthcare.

Scientific Validation and Ingredient Innovation Accelerate Adoption

Future development will be shaped by increasing clinical research on NMN, NR, and other NAD+ precursors, which is improving consumer trust and regulatory acceptance. Innovation in stabilization technology, sustained-release capsules, and enhanced-bioavailability formulations (such as liposomal or microencapsulated NAD+ boosters) is expected to differentiate brands and raise product efficacy. Companies are also developing novel precursor combinations to expand the biological pathways for NAD+ synthesis.

Regulatory Standardization and Quality Compliance Will Become Critical

As NAD+ boosters gain popularity, more stringent global regulations are emerging to ensure safety, purity, and label accuracy—especially in the U.S., EU, and China. The industry is shifting toward pharmaceutical-grade manufacturing, third-party testing, and validated human trials. Brands able to meet future compliance standards and provide transparent clinical data will dominate premium segments, while lower-quality manufacturers may be pressured out of the market.

Expansion into Personalized Nutrition and Integrated Health Ecosystems

Future growth will increasingly come from personalized supplementation, digital health integration, and subscription-based models. NAD+ booster capsules will be combined with biomarker testing, mitochondrial support formulas, gut-health products, and AI-driven health monitoring platforms. Partnerships with longevity clinics, anti-aging centers, and wellness programs will help capsules evolve from stand-alone supplements into components of broader metabolic and cellular-health ecosystems.

This report delivers a comprehensive overview of the global NAD+ Health Products market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding NAD+ Health Products. The NAD+ Health Products market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global NAD+ Health Products market comprehensively. Regional market sizes by Type, by Application, by Form, and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist NAD+ Health Products manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of NAD+ Health Products Market Report

Report Metric	Details
Report Name	NAD+ Health Products Market
Accounted market size in 2025	US$ 577 million
Forecasted market size in 2032	US$ 1528 million
CAGR	15.2%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	NMNContent ＜98% NMNContent ≥98%
Segment by Form	Powder Liquid Others
Segment by Ingestion Method	Oral Type Non-oral Type
Segment by Application	Health Care Products Beauty Products Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	GeneHarbor, Niagen Bioscience, Mirailab Bioscience Inc. (Shinkowa Pharmaceutical), Herbalmax, EffePharm, Kingdomway, NOMON Co., Ltd. (Teijin), CELFULL, Bontac, Genex Formulas, EZZ, Maac10 Formulas, Elysium Health
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Form, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for NAD+ Health Products companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is NAD+ Health Products Market growing?

Ans: The NAD+ Health Products Market witnessing a CAGR of 15.2% during the forecast period 2026-2032.

What is the NAD+ Health Products Market size in 2032?

Ans: The NAD+ Health Products Market size in 2032 will be US$ 1528 million.

Who are the main players in the NAD+ Health Products Market report?

Ans: The main players in the NAD+ Health Products Market are GeneHarbor, Niagen Bioscience, Mirailab Bioscience Inc. (Shinkowa Pharmaceutical), Herbalmax, EffePharm, Kingdomway, NOMON Co., Ltd. (Teijin), CELFULL, Bontac, Genex Formulas, EZZ, Maac10 Formulas, Elysium Health

What are the Application segmentation covered in the NAD+ Health Products Market report?

Ans: The Applications covered in the NAD+ Health Products Market report are Health Care Products, Beauty Products, Others

What are the Type segmentation covered in the NAD+ Health Products Market report?

Ans: The Types covered in the NAD+ Health Products Market report are NMNContent ＜98%, NMNContent ≥98%

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global NAD+ Health Products Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 NMNContent ＜98%

1.2.3 NMNContent ≥98%

1.3 Market by Form

1.3.1 Global NAD+ Health Products Market Size Growth Rate by Form: 2021 vs 2025 vs 2032

1.3.2 Powder

1.3.3 Liquid

1.3.4 Others

1.4 Market by Ingestion Method

1.4.1 Global NAD+ Health Products Market Size Growth Rate by Ingestion Method: 2021 vs 2025 vs 2032

1.4.2 Oral Type

1.4.3 Non-oral Type

1.5 Market by Application

1.5.1 Global NAD+ Health Products Market Growth by Application: 2021 vs 2025 vs 2032

1.5.2 Health Care Products

1.5.3 Beauty Products

1.5.4 Others

1.6 Assumptions and Limitations

1.7 Study Objectives

1.8 Years Considered

2 Global Growth Trends

2.1 Global NAD+ Health Products Market Perspective (2021–2032)

2.2 Global NAD+ Health Products Growth Trends by Region

2.2.1 Global NAD+ Health Products Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 NAD+ Health Products Historic Market Size by Region (2021–2026)

2.2.3 NAD+ Health Products Forecasted Market Size by Region (2027–2032)

2.3 NAD+ Health Products Market Dynamics

2.3.1 NAD+ Health Products Industry Trends

2.3.2 NAD+ Health Products Market Drivers

2.3.3 NAD+ Health Products Market Challenges

2.3.4 NAD+ Health Products Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top NAD+ Health Products Players by Revenue

3.1.1 Global Top NAD+ Health Products Players by Revenue (2021–2026)

3.1.2 Global NAD+ Health Products Revenue Market Share by Players (2021–2026)

3.2 Global Top NAD+ Health Products Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by NAD+ Health Products Revenue

3.4 Global NAD+ Health Products Market Concentration Ratio

3.4.1 Global NAD+ Health Products Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by NAD+ Health Products Revenue in 2025

3.5 Global Key Players of NAD+ Health Products Head Offices and Areas Served

3.6 Global Key Players of NAD+ Health Products, Products and Applications

3.7 Global Key Players of NAD+ Health Products, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 NAD+ Health Products Breakdown Data by Type

4.1 Global NAD+ Health Products Historic Market Size by Type (2021–2026)

4.2 Global NAD+ Health Products Forecasted Market Size by Type (2027–2032)

5 NAD+ Health Products Breakdown Data by Application

5.1 Global NAD+ Health Products Historic Market Size by Application (2021–2026)

5.2 Global NAD+ Health Products Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America NAD+ Health Products Market Size (2021–2032)

6.2 North America NAD+ Health Products Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America NAD+ Health Products Market Size by Country (2021–2026)

6.4 North America NAD+ Health Products Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe NAD+ Health Products Market Size (2021–2032)

7.2 Europe NAD+ Health Products Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe NAD+ Health Products Market Size by Country (2021–2026)

7.4 Europe NAD+ Health Products Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific NAD+ Health Products Market Size (2021–2032)

8.2 Asia-Pacific NAD+ Health Products Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific NAD+ Health Products Market Size by Region (2021–2026)

8.4 Asia-Pacific NAD+ Health Products Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America NAD+ Health Products Market Size (2021–2032)

9.2 Latin America NAD+ Health Products Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America NAD+ Health Products Market Size by Country (2021–2026)

9.4 Latin America NAD+ Health Products Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa NAD+ Health Products Market Size (2021–2032)

10.2 Middle East & Africa NAD+ Health Products Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa NAD+ Health Products Market Size by Country (2021–2026)

10.4 Middle East & Africa NAD+ Health Products Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 GeneHarbor

11.1.1 GeneHarbor Company Details

11.1.2 GeneHarbor Business Overview

11.1.3 GeneHarbor NAD+ Health Products Introduction

11.1.4 GeneHarbor Revenue in NAD+ Health Products Business (2021–2026)

11.1.5 GeneHarbor Recent Development

11.2 Niagen Bioscience

11.2.1 Niagen Bioscience Company Details

11.2.2 Niagen Bioscience Business Overview

11.2.3 Niagen Bioscience NAD+ Health Products Introduction

11.2.4 Niagen Bioscience Revenue in NAD+ Health Products Business (2021–2026)

11.2.5 Niagen Bioscience Recent Development

11.3 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical)

11.3.1 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Company Details

11.3.2 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Business Overview

11.3.3 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) NAD+ Health Products Introduction

11.3.4 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Revenue in NAD+ Health Products Business (2021–2026)

11.3.5 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Recent Development

11.4 Herbalmax

11.4.1 Herbalmax Company Details

11.4.2 Herbalmax Business Overview

11.4.3 Herbalmax NAD+ Health Products Introduction

11.4.4 Herbalmax Revenue in NAD+ Health Products Business (2021–2026)

11.4.5 Herbalmax Recent Development

11.5 EffePharm

11.5.1 EffePharm Company Details

11.5.2 EffePharm Business Overview

11.5.3 EffePharm NAD+ Health Products Introduction

11.5.4 EffePharm Revenue in NAD+ Health Products Business (2021–2026)

11.5.5 EffePharm Recent Development

11.6 Kingdomway

11.6.1 Kingdomway Company Details

11.6.2 Kingdomway Business Overview

11.6.3 Kingdomway NAD+ Health Products Introduction

11.6.4 Kingdomway Revenue in NAD+ Health Products Business (2021–2026)

11.6.5 Kingdomway Recent Development

11.7 NOMON Co., Ltd. (Teijin)

11.7.1 NOMON Co., Ltd. (Teijin) Company Details

11.7.2 NOMON Co., Ltd. (Teijin) Business Overview

11.7.3 NOMON Co., Ltd. (Teijin) NAD+ Health Products Introduction

11.7.4 NOMON Co., Ltd. (Teijin) Revenue in NAD+ Health Products Business (2021–2026)

11.7.5 NOMON Co., Ltd. (Teijin) Recent Development

11.8 CELFULL

11.8.1 CELFULL Company Details

11.8.2 CELFULL Business Overview

11.8.3 CELFULL NAD+ Health Products Introduction

11.8.4 CELFULL Revenue in NAD+ Health Products Business (2021–2026)

11.8.5 CELFULL Recent Development

11.9 Bontac

11.9.1 Bontac Company Details

11.9.2 Bontac Business Overview

11.9.3 Bontac NAD+ Health Products Introduction

11.9.4 Bontac Revenue in NAD+ Health Products Business (2021–2026)

11.9.5 Bontac Recent Development

11.10 Genex Formulas

11.10.1 Genex Formulas Company Details

11.10.2 Genex Formulas Business Overview

11.10.3 Genex Formulas NAD+ Health Products Introduction

11.10.4 Genex Formulas Revenue in NAD+ Health Products Business (2021–2026)

11.10.5 Genex Formulas Recent Development

11.11 EZZ

11.11.1 EZZ Company Details

11.11.2 EZZ Business Overview

11.11.3 EZZ NAD+ Health Products Introduction

11.11.4 EZZ Revenue in NAD+ Health Products Business (2021–2026)

11.11.5 EZZ Recent Development

11.12 Maac10 Formulas

11.12.1 Maac10 Formulas Company Details

11.12.2 Maac10 Formulas Business Overview

11.12.3 Maac10 Formulas NAD+ Health Products Introduction

11.12.4 Maac10 Formulas Revenue in NAD+ Health Products Business (2021–2026)

11.12.5 Maac10 Formulas Recent Development

11.13 Elysium Health

11.13.1 Elysium Health Company Details

11.13.2 Elysium Health Business Overview

11.13.3 Elysium Health NAD+ Health Products Introduction

11.13.4 Elysium Health Revenue in NAD+ Health Products Business (2021–2026)

11.13.5 Elysium Health Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

GeneHarbor

Mirailab Bioscience Inc. (Shinkowa Pharmaceutical)

Herbalmax

EffePharm

Kingdomway

NOMON Co., Ltd. (Teijin)

List of Tables

Table 1. Global NAD+ Health Products Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of NMNContent ＜98%

Table 3. Key Players of NMNContent ≥98%

Table 4. Global NAD+ Health Products Market Size Growth Rate by Form (US$ Million): 2021 vs 2025 vs 2032

Table 5. Key Players of Powder

Table 6. Key Players of Liquid

Table 7. Key Players of Others

Table 8. Global NAD+ Health Products Market Size Growth Rate by Ingestion Method (US$ Million): 2021 vs 2025 vs 2032

Table 9. Key Players of Oral Type

Table 10. Key Players of Non-oral Type

Table 11. Global NAD+ Health Products Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 12. Global NAD+ Health Products Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 13. Global NAD+ Health Products Market Size by Region (US$ Million), 2021–2026

Table 14. Global NAD+ Health Products Market Share by Region (2021–2026)

Table 15. Global NAD+ Health Products Forecasted Market Size by Region (US$ Million), 2027–2032

Table 16. Global NAD+ Health Products Market Share by Region (2027–2032)

Table 17. NAD+ Health Products Market Trends

Table 18. NAD+ Health Products Market Drivers

Table 19. NAD+ Health Products Market Challenges

Table 20. NAD+ Health Products Market Restraints

Table 21. Global NAD+ Health Products Revenue by Players (US$ Million), 2021–2026

Table 22. Global NAD+ Health Products Market Share by Players (2021–2026)

Table 23. Global Top NAD+ Health Products Players by Tier (Tier 1, Tier 2, and Tier 3), based on NAD+ Health Products Revenue, 2025

Table 24. Ranking of Global Top NAD+ Health Products Companies by Revenue (US$ Million) in 2025

Table 25. Global 5 Largest Players Market Share by NAD+ Health Products Revenue (CR5 and HHI), 2021–2026

Table 26. Global Key Players of NAD+ Health Products, Headquarters and Area Served

Table 27. Global Key Players of NAD+ Health Products, Products and Applications

Table 28. Global Key Players of NAD+ Health Products, Date of General Availability (GA)

Table 29. Mergers and Acquisitions, Expansion Plans

Table 30. Global NAD+ Health Products Market Size by Type (US$ Million), 2021–2026

Table 31. Global NAD+ Health Products Revenue Market Share by Type (2021–2026)

Table 32. Global NAD+ Health Products Forecasted Market Size by Type (US$ Million), 2027–2032

Table 33. Global NAD+ Health Products Revenue Market Share by Type (2027–2032)

Table 34. Global NAD+ Health Products Market Size by Application (US$ Million), 2021–2026

Table 35. Global NAD+ Health Products Revenue Market Share by Application (2021–2026)

Table 36. Global NAD+ Health Products Forecasted Market Size by Application (US$ Million), 2027–2032

Table 37. Global NAD+ Health Products Revenue Market Share by Application (2027–2032)

Table 38. North America NAD+ Health Products Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 39. North America NAD+ Health Products Market Size by Country (US$ Million), 2021–2026

Table 40. North America NAD+ Health Products Market Size by Country (US$ Million), 2027–2032

Table 41. Europe NAD+ Health Products Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 42. Europe NAD+ Health Products Market Size by Country (US$ Million), 2021–2026

Table 43. Europe NAD+ Health Products Market Size by Country (US$ Million), 2027–2032

Table 44. Asia-Pacific NAD+ Health Products Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 45. Asia-Pacific NAD+ Health Products Market Size by Region (US$ Million), 2021–2026

Table 46. Asia-Pacific NAD+ Health Products Market Size by Region (US$ Million), 2027–2032

Table 47. Latin America NAD+ Health Products Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 48. Latin America NAD+ Health Products Market Size by Country (US$ Million), 2021–2026

Table 49. Latin America NAD+ Health Products Market Size by Country (US$ Million), 2027–2032

Table 50. Middle East & Africa NAD+ Health Products Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 51. Middle East & Africa NAD+ Health Products Market Size by Country (US$ Million), 2021–2026

Table 52. Middle East & Africa NAD+ Health Products Market Size by Country (US$ Million), 2027–2032

Table 53. GeneHarbor Company Details

Table 54. GeneHarbor Business Overview

Table 55. GeneHarbor NAD+ Health Products Product

Table 56. GeneHarbor Revenue in NAD+ Health Products Business (US$ Million), 2021–2026

Table 57. GeneHarbor Recent Development

Table 58. Niagen Bioscience Company Details

Table 59. Niagen Bioscience Business Overview

Table 60. Niagen Bioscience NAD+ Health Products Product

Table 61. Niagen Bioscience Revenue in NAD+ Health Products Business (US$ Million), 2021–2026

Table 62. Niagen Bioscience Recent Development

Table 63. Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Company Details

Table 64. Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Business Overview

Table 65. Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) NAD+ Health Products Product

Table 66. Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Revenue in NAD+ Health Products Business (US$ Million), 2021–2026

Table 67. Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Recent Development

Table 68. Herbalmax Company Details

Table 69. Herbalmax Business Overview

Table 70. Herbalmax NAD+ Health Products Product

Table 71. Herbalmax Revenue in NAD+ Health Products Business (US$ Million), 2021–2026

Table 72. Herbalmax Recent Development

Table 73. EffePharm Company Details

Table 74. EffePharm Business Overview

Table 75. EffePharm NAD+ Health Products Product

Table 76. EffePharm Revenue in NAD+ Health Products Business (US$ Million), 2021–2026

Table 77. EffePharm Recent Development

Table 78. Kingdomway Company Details

Table 79. Kingdomway Business Overview

Table 80. Kingdomway NAD+ Health Products Product

Table 81. Kingdomway Revenue in NAD+ Health Products Business (US$ Million), 2021–2026

Table 82. Kingdomway Recent Development

Table 83. NOMON Co., Ltd. (Teijin) Company Details

Table 84. NOMON Co., Ltd. (Teijin) Business Overview

Table 85. NOMON Co., Ltd. (Teijin) NAD+ Health Products Product

Table 86. NOMON Co., Ltd. (Teijin) Revenue in NAD+ Health Products Business (US$ Million), 2021–2026

Table 87. NOMON Co., Ltd. (Teijin) Recent Development

Table 88. CELFULL Company Details

Table 89. CELFULL Business Overview

Table 90. CELFULL NAD+ Health Products Product

Table 91. CELFULL Revenue in NAD+ Health Products Business (US$ Million), 2021–2026

Table 92. CELFULL Recent Development

Table 93. Bontac Company Details

Table 94. Bontac Business Overview

Table 95. Bontac NAD+ Health Products Product

Table 96. Bontac Revenue in NAD+ Health Products Business (US$ Million), 2021–2026

Table 97. Bontac Recent Development

Table 98. Genex Formulas Company Details

Table 99. Genex Formulas Business Overview

Table 100. Genex Formulas NAD+ Health Products Product

Table 101. Genex Formulas Revenue in NAD+ Health Products Business (US$ Million), 2021–2026

Table 102. Genex Formulas Recent Development

Table 103. EZZ Company Details

Table 104. EZZ Business Overview

Table 105. EZZ NAD+ Health Products Product

Table 106. EZZ Revenue in NAD+ Health Products Business (US$ Million), 2021–2026

Table 107. EZZ Recent Development

Table 108. Maac10 Formulas Company Details

Table 109. Maac10 Formulas Business Overview

Table 110. Maac10 Formulas NAD+ Health Products Product

Table 111. Maac10 Formulas Revenue in NAD+ Health Products Business (US$ Million), 2021–2026

Table 112. Maac10 Formulas Recent Development

Table 113. Elysium Health Company Details

Table 114. Elysium Health Business Overview

Table 115. Elysium Health NAD+ Health Products Product

Table 116. Elysium Health Revenue in NAD+ Health Products Business (US$ Million), 2021–2026

Table 117. Elysium Health Recent Development

Table 118. Research Programs/Design for This Report

Table 119. Key Data Information from Secondary Sources

Table 120. Key Data Information from Primary Sources

Table 121. Authors List of This Report

List of Figures

Figure 1. NAD+ Health Products Picture

Figure 2. Global NAD+ Health Products Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global NAD+ Health Products Market Share by Type: 2025 vs 2032

Figure 4. NMNContent ＜98% Features

Figure 5. NMNContent ≥98% Features

Figure 6. Global NAD+ Health Products Market Size Comparison by Form (US$ Million), 2021–2032

Figure 7. Powder Features

Figure 8. Liquid Features

Figure 9. Others Features

Figure 10. Global NAD+ Health Products Market Size Comparison by Ingestion Method (US$ Million), 2021–2032

Figure 11. Oral Type Features

Figure 12. Non-oral Type Features

Figure 13. Global NAD+ Health Products Market Size by Application (US$ Million), 2021–2032

Figure 14. Global NAD+ Health Products Market Share by Application: 2025 vs 2032

Figure 15. Health Care Products Case Studies

Figure 16. Beauty Products Case Studies

Figure 17. Others Case Studies

Figure 18. NAD+ Health Products Report Years Considered

Figure 19. Global NAD+ Health Products Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 20. Global NAD+ Health Products Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 21. Global NAD+ Health Products Market Share by Region: 2025 vs 2032

Figure 22. Global NAD+ Health Products Market Share by Players in 2025

Figure 23. Global NAD+ Health Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 24. The Top 10 and 5 Players Market Share by NAD+ Health Products Revenue in 2025

Figure 25. North America NAD+ Health Products Market Size YoY Growth (US$ Million), 2021–2032

Figure 26. North America NAD+ Health Products Market Share by Country (2021–2032)

Figure 27. United States NAD+ Health Products Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. Canada NAD+ Health Products Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. Europe NAD+ Health Products Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Europe NAD+ Health Products Market Share by Country (2021–2032)

Figure 31. Germany NAD+ Health Products Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. France NAD+ Health Products Market Size YoY Growth (US$ Million), 2021–2032

Figure 33. U.K. NAD+ Health Products Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. Italy NAD+ Health Products Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. Russia NAD+ Health Products Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. Ireland NAD+ Health Products Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. Asia-Pacific NAD+ Health Products Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Asia-Pacific NAD+ Health Products Market Share by Region (2021–2032)

Figure 39. China NAD+ Health Products Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Japan NAD+ Health Products Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. South Korea NAD+ Health Products Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Southeast Asia NAD+ Health Products Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. India NAD+ Health Products Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Australia & New Zealand NAD+ Health Products Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. Latin America NAD+ Health Products Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. Latin America NAD+ Health Products Market Share by Country (2021–2032)

Figure 47. Mexico NAD+ Health Products Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. Brazil NAD+ Health Products Market Size YoY Growth (US$ Million), 2021–2032

Figure 49. Middle East & Africa NAD+ Health Products Market Size YoY Growth (US$ Million), 2021–2032

Figure 50. Middle East & Africa NAD+ Health Products Market Share by Country (2021–2032)

Figure 51. Israel NAD+ Health Products Market Size YoY Growth (US$ Million), 2021–2032

Figure 52. Saudi Arabia NAD+ Health Products Market Size YoY Growth (US$ Million), 2021–2032

Figure 53. UAE NAD+ Health Products Market Size YoY Growth (US$ Million), 2021–2032

Figure 54. GeneHarbor Revenue Growth Rate in NAD+ Health Products Business (2021–2026)

Figure 55. Niagen Bioscience Revenue Growth Rate in NAD+ Health Products Business (2021–2026)

Figure 56. Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Revenue Growth Rate in NAD+ Health Products Business (2021–2026)

Figure 57. Herbalmax Revenue Growth Rate in NAD+ Health Products Business (2021–2026)

Figure 58. EffePharm Revenue Growth Rate in NAD+ Health Products Business (2021–2026)

Figure 59. Kingdomway Revenue Growth Rate in NAD+ Health Products Business (2021–2026)

Figure 60. NOMON Co., Ltd. (Teijin) Revenue Growth Rate in NAD+ Health Products Business (2021–2026)

Figure 61. CELFULL Revenue Growth Rate in NAD+ Health Products Business (2021–2026)

Figure 62. Bontac Revenue Growth Rate in NAD+ Health Products Business (2021–2026)

Figure 63. Genex Formulas Revenue Growth Rate in NAD+ Health Products Business (2021–2026)

Figure 64. EZZ Revenue Growth Rate in NAD+ Health Products Business (2021–2026)

Figure 65. Maac10 Formulas Revenue Growth Rate in NAD+ Health Products Business (2021–2026)

Figure 66. Elysium Health Revenue Growth Rate in NAD+ Health Products Business (2021–2026)

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions